NCT00005760 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Mokdad AH, Serdula MK, Dietz WH, Bowman BA, Marks JS, Koplan JP
The spread of the obesity epidemic in the United States, 1991-1998. JAMA. 1999 Oct 27;282(16):1519-22.
Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH
The disease burden associated with overweight and obesity. JAMA. 1999 Oct 27;282(16):1523-9.
Pi-Sunyer FX, Laferrère B, Aronne LJ, Bray GA
Therapeutic controversy: Obesity--a modern-day epidemic. J Clin Endocrinol Metab. 1999 Jan;84(1):3-12.

A Pilot Study of the Metabolic Effects of Large Volume Liposuction in Overweight Women With Hyperinsulinemia, Impaired Glucose Tolerance and/or Type 2 Diabetes

Details for clinical trial NCT00005760

Clinical trial NCT00005760 - References